Pinnacle Wealth Planning Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Pinnacle Wealth Planning Services's BIIB Position: Q1 2026 in Review
Pinnacle Wealth Planning Services increased its Biogen (BIIB) stake by 0.98% in Q1 2026, buying an estimated $1.84K and bringing the position to 1,030 shares worth $189K. The position accounts for 0.02% of the portfolio, ranked #500.
Pinnacle Wealth Planning Services first reported a position in BIIB in Q4 2017 and has held it in 15 quarters since. The position peaked at $434K in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Pinnacle Wealth Planning Services held 1,030 shares of Biogen worth $189K as of Q1 2026.
- Pinnacle Wealth Planning Services bought 10 Biogen shares in Q1 2026, an estimated $1.84K.
- Biogen made up 0.02% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #500 holding.
- Pinnacle Wealth Planning Services first reported a position in Biogen in Q4 2017 and has held it in 15 quarters since.
- Pinnacle Wealth Planning Services's Biogen position peaked at $434K in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.